File:CRONaxal Clinical Case Studies, via Alan Cash of Terra Biological LLC.png

Summary
"CRONaxal Clinical Case Studies, via Alan Cash, Terra Biological LLC" : evidence put forward by Alan Cash to show the efficacy of CRONaxal in the "Dietary Management of Brain Cancer".

Source ... https://www.dropbox.com/sh/fijgzi7p2lkknay/AACnFzGCrMHLOjN7iDGfRYFsa?dl=0&preview=Glioblastoma+Poster+3.pptx

[ Color-coding not on original, it was added by moi Guvax (talk) 07:15, 26 February 2017 (UTC)]

Low-grade oligodendrogliomas are usually slow-growing tumors that can be indolent for years. So that such tumors haven't grown over a period of months is nothing to write home about, (i.e. their lack of growth over that period is not evidence of efficacy).

The cases marked "Waiting on MRI" are just padding this table: they're not evidence.

If you exclude the cases marked "progressive" (i.e. tumor growth), "low-grade oligodendrogliomas", and "Waiting on MRI", then that leaves just ten cases of "no growth" or "tumor reduction", seven of which were on proven chemotherapy at the time.